Abrdn PLC Repligen Corp Transaction History

Abrdn PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$120.0 - $182.95 $49,440 - $75,375	412 Added 8.05%	5,531 $697,000
Q1 2024 May 08, 2024	SELL	$170.78 - $208.42 $12,466 - $15,214	-73 Reduced 1.41%	5,119 $941,000
Q4 2023 Jan 31, 2024	BUY	$114.17 - $185.35 $8,106 - $13,159	71 Added 1.39%	5,192 $933,000
Q3 2023 Nov 06, 2023	BUY	$138.78 - $176.51 $5,273 - $6,707	38 Added 0.75%	5,121 $814,000
Q2 2023 Jun 20, 2024	BUY	$138.42 - $180.31 $188,804 - $245,942	1,364 Added 36.68%	5,083 $719,000
Q2 2023 Aug 04, 2023	BUY	$138.42 - $180.31 $188,804 - $245,942	1,364 Added 36.68%	5,083 $719,000
Q1 2023 Jun 20, 2024	SELL	$154.26 - $198.1 $215,964 - $277,340	-1,400 Reduced 27.35%	3,719 $626,000
Q1 2023 Apr 28, 2023	BUY	$154.26 - $198.1 $573,692 - $736,733	3,719 New	3,719 $626,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.